Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus and Sirolimus vs Tacrolimus and MMF in Renal Transplantation
NCT00141804Phase 3Unknown
- Sponsor
- Universitätsklinikum Münster
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sirolimus in kidney transplant rejection (2 arms), sponsored by Universitätsklinikum Münster. Primary endpoints: Time to first biopsy proven acute rejection episode at 12 months, Graft failure at 12 months and 1 more. Status: unknown.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00141804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141804.